Search results for "PROs"

showing 10 items of 7271 documents

CONSISTENT BONE MARROW-DERIVED CELL MOBILIZATION FOLLOWING REPEATED SHORT COURSES OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH AMYOTROPH…

2009

Background and aims. The aim of this study was to evaluate and characterize the feasibility and safety of bone marrow-derived cell (BMC) mobilization following repeated courses of granulocyte-colony stimulating factor (G-CSF) in patients with amyotrophic lateral sclerosis (ALS). Methods. Between January 2006 and March 2007, 26 ALS patients entered a multicenter trial that included four courses of BMC mobilization at 3-month intervals. In each course, G-CSF (5 mu g/kg b.i.d.) was administered for four consecutive days; 18% mannitol was also given. Mobilization was monitored by flow cytometry analysis of circulating CD34(+) cells and by in vitro colony assay for clonogenic progenitors. Co-exp…

AdultMaleCancer Researchmedicine.medical_specialtySLa - trial clinico - C-GSFImmunologyAntigens CD34Bone Marrow CellsDrug Administration ScheduleColony-Forming Units AssayCell MovementInternal medicineMulticenter trialmedicineImmunology and AllergyHumansCell LineageProspective StudiesAmyotrophic lateral sclerosisProspective cohort studyGenetics (clinical)Hematopoietic Stem Cell MobilizationNeuronsTransplantationMobilizationbusiness.industryStem CellsAmyotrophic Lateral SclerosisGranulocyte-Macrophage Colony-Stimulating FactorCell DifferentiationCell BiologyMiddle Agedmedicine.diseaseHematopoietic Stem CellsBone Marrow-Derived CellHematopoietic Stem Cell MobilizationSurgeryGranulocyte colony-stimulating factorNerve RegenerationSettore MED/26 - NEUROLOGIAGranulocyte macrophage colony-stimulating factorTreatment OutcomeOncologyBiological MarkersFemalebusinessNeurogliaBiomarkersmedicine.drug
researchProduct

p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or again…

2000

The aim of this study was to determine whether p53 is helpful in making the decision to undergo cystectomy in T1, G3 transitional cell carcinoma (TCC) of the bladder, by prospectively comparing the p53 status of bladder biopsies with the histology and p53 status of the corresponding cystectomy specimens. From January 1996 to August 1997, 38 consecutive patients with T1G3 TCC at 6 different centres were enrolled into the study. Bladder biopsies and cystectomy specimens were examined with three different antibodies against p53. The p53 status of each bladder biopsy was compared with p53 status, tumour stage and grade of the cystectomy specimen. An independent evaluation of the histology and i…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentBiopsyUrinary BladderUrologyCystectomyCystectomyBiopsymedicineHumansProspective StudiesAgedNeoplasm StagingCarcinoma Transitional CellBladder cancerUrinary bladdermedicine.diagnostic_testbusiness.industryHistologyMiddle Agedmedicine.diseaseImmunohistochemistrySurgeryTransitional cell carcinomamedicine.anatomical_structureOncologyUrinary Bladder NeoplasmsImmunohistochemistryHistopathologyFemaleTumor Suppressor Protein p53businessEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Pain Mechanisms Involved and Outcome in Advanced Cancer Patients with Possible Indications for Celiac Plexus Block and Superior Hypogastric Plexus Bl…

2002

Aims and Background There is controversy about the role of neurolytic sympathetic blocks in advanced cancer, when pain syndromes may assume other characteristics, with a possible involvement of structures other than visceral. The aim of the present study was to assess the pain characteristics and the analgesic response of a consecutive sample of home care patients with pancreatic and pelvic pain, which would have possible indications for a celiac plexus block and a superior hypogastric block, respectively. Methods From January 1999 to December 1999, 400 consecutive advanced cancer patients were surveyed for a prospective longitudinal survey. We considered only patients who had pancreatic ca…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentCeliac plexusCeliac Plexus030218 nuclear medicine & medical imagingmedicine.nerve03 medical and health sciences0302 clinical medicineNeoplasmsPancreatic cancerSuperior hypogastric plexusmedicineHumansLongitudinal StudiesProspective StudiesProspective cohort studyAgedHypogastric PlexusPain mechanismbusiness.industryPelvic painCeliac plexus blockNerve BlockHypogastric PlexusGeneral MedicineMiddle Agedmedicine.diseaseAdvanced cancer patientSurgeryAnalgesics OpioidTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisNeuralgiaNerve blockNeuralgiaProspective longitudinal studyFemalemedicine.symptombusinessSuperior hypogastric plexus blockTumori Journal
researchProduct

Protective effect of amifostine on dental health after radiotherapy of the head and neck.

2000

Abstract Purpose: The cytoprotective agent amifostine has been shown to reduce the radiation-induced acute and chronic xerostomia in head and neck cancer patients. The purpose of this study was to evaluate whether or not amifostine also reduces the incidence of dental caries associated with the radiation-induced xerostomia. Methods and Materials: The dental status before and 1 year after radiotherapy was retrospectively compared in 35 unselected patients treated as part of the prospective randomized and multicenter open-label Phase III study (WR-38) at the University Hospitals of Heidelberg, Freiburg, and Erlangen. The WR-38 study compared radiotherapy in head and neck cancer with and witho…

AdultMaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentRadiation-Protective AgentsDental CariesXerostomiasymbols.namesakeAmifostinestomatognathic systemOral and maxillofacial pathologymedicineClinical endpointHumansRadiology Nuclear Medicine and imagingProspective StudiesRadiation InjuriesFisher's exact testAgedRetrospective StudiesRadiationbusiness.industryHead and neck cancerCase-control studyAmifostineMiddle Agedmedicine.diseaseSurgeryRadiation therapystomatognathic diseasesOncologyHead and Neck NeoplasmsConcomitantsymbolsFemalebusinessmedicine.drugInternational journal of radiation oncology, biology, physics
researchProduct

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.

2004

Contains fulltext : 57114.pdf (Publisher’s version ) (Closed access) Chimeric monoclonal antibody G250 (WX-G250) binds to a cell surface antigen found on >90% of renal cell carcinoma (RCC). A multicentre phase II study was performed to evaluate the safety and efficacy of WX-G250 in metastatic RCC (mRCC) patients. In all, 36 patients with mRCC were included. WX-G250 was given weekly by intravenous infusion for 12 weeks. Patients with stable disease (SD) or response were eligible to receive additional treatment for 8 weeks. None of the 36 enrolled patients experienced any drug-related grade III or IV toxicity. Only three patients had grade II toxicity possibly related to the study medication.…

AdultMaleCancer Researchmedicine.medical_specialtyrenal cell carcinomaRecombinant Fusion ProteinsPhases of clinical researchAntineoplastic AgentsGastroenterologyClinicalMonoclonal antibody G250Renal cell carcinomaInternal medicinemedicineCarcinomaHumansProspective StudiesCarcinoma Renal CellAgedbusiness.industryGirentuximabAntibodies MonoclonalImmunotherapy gene therapy and transplantation [UMCN 1.4]CA-IXMiddle Agedmedicine.diseaseKidney NeoplasmsSurgeryClinical trialTreatment OutcomeOncologymonoclonal antibodyAntigens SurfaceFemaleimmunotherapybusinessWX-G250Progressive diseasemedicine.drugKidney disease
researchProduct

Association Between Individual and Combined SNPs in Genes Related to Innate Immunity and Incidence of CMV Infection in Seropositive Kidney Transplant…

2014

In this study, we assessed the association between single-nucleotide polymorphisms (SNPs) in seven candidate genes involved in orchestrating the immune response against cytomegalovirus (CMV) and the 12-month incidence of CMV infection in 315 CMV-seropositive kidney transplant (KT) recipients. Patients were managed either by antiviral prophylaxis or preemptive therapy. CMV infection occurred in 140 patients (44.4%), including 13 episodes of disease. After adjusting for various clinical covariates, patients harboring T-allele genotypes of interleukin-28B (IL28B) (rs12979860) SNP had lower incidence of CMV infection (adjusted hazard ratio [aHR]: 0.66; 95% confidence interval [CI]: 0.46-0.96; p…

AdultMaleCandidate geneGenotypeReceptors Cell SurfaceSingle-nucleotide polymorphismDiseasePolymorphism Single NucleotideImmune systemGenotypeOdds RatioHumansImmunology and AllergyMedicineSNPLectins C-TypePharmacology (medical)Prospective StudiesAllelesAgedProportional Hazards ModelsTransplantationbusiness.industryIncidenceInterleukinsHazard ratioTLR9Middle AgedKidney TransplantationImmunity InnateTransplant RecipientsCytomegalovirus InfectionsImmunologyKidney Failure ChronicFemaleInterferonsbusinessCell Adhesion MoleculesAmerican Journal of Transplantation
researchProduct

Cerebral oxygen saturation and cardiac output during anaesthesia in sitting position for neurosurgical procedures: a prospective observational study.

2016

Abstract Background Neurosurgical operations in the dorsal cranium often require the patient to be positioned in a sitting position. This can be associated with decreased cardiac output and cerebral hypoperfusion, and possibly, inadequate cerebral oxygenation. In the present study, cerebral oxygen saturation was measured during neurosurgery in the sitting position and correlated with cardiac output. Methods Perioperative cerebral oxygen saturation was measured continuously with two different monitors, INVOS® and FORE-SIGHT®. Cardiac output was measured at eight predefined time points using transoesophageal echocardiography. Results Forty patients were enrolled, but only 35 (20 female) were …

AdultMaleCardiac outputmedicine.medical_specialtyDecreased cardiac outputCerebral oxygen saturationSittingNeurosurgical ProceduresPatient Positioning03 medical and health sciences0302 clinical medicine030202 anesthesiologymedicineHumansAnesthesiaArterial PressureProspective StudiesCardiac OutputAgedbusiness.industryBrain030208 emergency & critical care medicinePerioperativeMiddle AgedOxygenOxygen Saturation MeasurementAnesthesiology and Pain MedicineBlood pressureAnesthesiaFemaleNeurosurgerybusinessBritish journal of anaesthesia
researchProduct

Real-time, ultrasound-guided infraclavicular axillary vein cannulation for renal replacement therapy in the critical care unit—A prospective interven…

2015

Abstract Purpose The cannulation of the axillary vein for renal replacement therapy is a rarely performed procedure in the critical care unit. We defined the venipuncture and catheterization success rates and early mechanical complication rates of this technique in critical care patients with acute kidney injury. Materials and methods Twenty-nine mechanically ventilated patients with clinical indications for insertion of temporary hemodialysis catheters enrolled in a registered trial (NCT01919528) as a pilot cohort. We performed 29 real-time, ultrasound-guided infraclavicular axillary vein cannulation attempts for renal replacement therapy. We defined the venipuncture and catheterization su…

AdultMaleCatheterization Central Venousmedicine.medical_specialtyCritical Caremedicine.medical_treatmentHemodialysis CatheterPilot ProjectsCritical Care and Intensive Care Medicinelaw.inventionCohort StudiesRenal DialysislawPerformed ProcedureHumansMedicineProspective StudiesRenal InsufficiencyRenal replacement therapyAxillary VeinUltrasonography InterventionalAgedAged 80 and overVenipuncturebusiness.industryAcute kidney injuryMiddle Agedmedicine.diseaseIntensive care unitSurgeryRenal Replacement TherapyIntensive Care UnitsAnesthesiaFemalebusinessComplicationAxillary veinJournal of Critical Care
researchProduct

A new Infraclavicular Landmark-Based Approach to the Axillary Vein as an Alternative Method of Central Venous Cannulation

2016

Purpose: We developed the new technique of the axillary vein catheterization, which is connected with the determination of only two anatomical points of reference for puncture site identification. The primary outcome of this study was to determine the rate of successful catheterizations and the assessment of procedure success rate, depending on cannulation side as well as physician experience. The secondary objective was to evaluate the early complication rate and to determine whether this method can be used in clinical practice. Methods: The methodology of this prospective, cohort study included catheterization of the axillary vein via the infraclavicular approach. All procedures were perf…

AdultMaleCatheterization Central Venousmedicine.medical_specialtyTime FactorsTreatment outcomePunctures030204 cardiovascular system & hematologyCatheterizationYoung Adult03 medical and health sciencesCatheters Indwelling0302 clinical medicineRisk FactorsIntensive careCatheterization PeripheralmedicineCentral Venous CathetersHumansProspective StudiesProspective cohort studyAgedAged 80 and overAlternative methodsLandmarkbusiness.industryAxillary vein030208 emergency & critical care medicineMiddle AgedSurgeryTreatment OutcomeNephrologyIntensive careFemaleSurgeryClinical CompetenceRadiologyAnatomic LandmarksClinical competencebusinessAxillary veinLearning CurveVenous cannulationThe Journal of Vascular Access
researchProduct

Evaluation of inflammatory reactions and genotoxic effects after exposure of nasal respiratory epithelia to benzene.

2003

<i>Background:</i> The aim of this study was to identify inflammatory changes as well as genotoxic effects in cultivated human respiratory epithelial cells after in vitro exposure to benzene. <i>Methods:</i> Primary cell cultures of nasal respiratory mucosa were exposed to synthetic air enriched with 5,000 µg/m<sup>3</sup> of benzene at an air/liquid interface over 8 h and then to synthetic air only over the following 24 h. Controls were continuously exposed to synthetic air over 32 h. To detect inflammatory reactions, release of prostaglandin E<sub>2</sub> was quantified using a competitive enzyme immunoassay. The Comet Assay was used to quan…

AdultMaleCell SurvivalInflammationDNA FragmentationDinoprostoneImmunoenzyme TechniquesmedicineHumansCiliaRespiratory systemskin and connective tissue diseasesNoseCells CulturedAgedInflammationintegumentary systembusiness.industryIn vitro exposureBenzeneMiddle AgedEpitheliumNasal Mucosamedicine.anatomical_structureOtorhinolaryngologyCell cultureToxicityImmunologyFemalesense organsComet Assaymedicine.symptombusinessRespiratory tractORL; journal for oto-rhino-laryngology and its related specialties
researchProduct